Skip to main content
Premium Trial:

Request an Annual Quote

Celera AgGen in Bovine Gene Deal with ViaLactia

Premium

ROCKVILLE, Md.--Celera Genomics' AgGen business, in a deal with New Zealand company ViaLactia Biosciences, will search for genes important for dairy productivity in the bovine genome. The deal calls for Celera to use its high-throughput DNA sequencing, library development, and advanced bioinformatics capabilities to identify important expressed genes in dairy cattle. ViaLactia, which has access to cattle populations, related phenotypic information, and knowledge of the dairy industry, plans to use the gene data for integrated breeding programs in New Zealand. Intellectual property resulting from the project will be jointly owned.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.